Clinical Trial Results:
A phase 4 randomized, double-blind study comparing
patient comfort and safety between iodixanol 320 mg I/ml
and iopamidol 370 mg I/ml in patients undergoing
contrast-enhanced computed tomographic (CECT) imaging
of the abdomen/pelvis
Summary
|
|
EudraCT number |
2011-000050-32 |
Trial protocol |
DE GB |
Global completion date |
27 Oct 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Jul 2016
|
First version publication date |
24 Jul 2016
|
Other versions |
|
Summary report(s) |
GE-012-097 CREP Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.